UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis

Neurochemical research, 2014-10, Vol.39 (10), p.2008-2017

2014

Volltextzugriff (PDF)

The Circuitry Mediating Cocaine-Induced Reinstatement of Drug-Seeking Behavior

The Journal of neuroscience, 2001-11, Vol.21 (21), p.8655-8663

2001

Volltextzugriff (PDF)

Brain circuitry and the reinstatement of cocaine-seeking behavior

Psychopharmacology, 2003-07, Vol.168 (1-2), p.44-56

2003

Volltextzugriff (PDF)

Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking

The Journal of neuroscience, 2005-07, Vol.25 (27), p.6389-6393

2005

Volltextzugriff (PDF)

Limbic and Motor Circuitry Underlying Footshock-Induced Reinstatement of Cocaine-Seeking Behavior

The Journal of neuroscience, 2004-02, Vol.24 (7), p.1551-1560

2004

Volltextzugriff (PDF)

Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse

Nature neuroscience, 2003-07, Vol.6 (7), p.743-749

2003

Volltextzugriff (PDF)

Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease

Behavioural pharmacology, 2011-10, Vol.22 (7), p.681-692

2011

Volltextzugriff (PDF)

Adenosine A2a Blockade Prevents Synergy between μ-Opiate and Cannabinoid CB1 Receptors and Eliminates Heroin-Seeking Behavior in Addicted Rats

Proceedings of the National Academy of Sciences - PNAS, 2006-05, Vol.103 (20), p.7877-7882

2006

Volltextzugriff (PDF)

Safety and Tolerability of N-Acetylcysteine in Cocaine-Dependent Individuals

The American journal on addictions, 2006-01, Vol.15 (1), p.105-110

2006

Volltextzugriff (PDF)

Activator of G Protein Signaling 3 Regulates Opiate Activation of Protein Kinase A Signaling and Relapse of Heroin-Seeking Behavior

Proceedings of the National Academy of Sciences - PNAS, 2005-06, Vol.102 (24), p.8746-8751

2005

Volltextzugriff (PDF)

Effects of haloperidol on cue-induced autonomic and behavioral indices of heroin reward and motivation

Psychopharmacology, 2003-07, Vol.168 (1-2), p.139-145

2003

Volltextzugriff (PDF)

Prefrontal Glutamate Release into the Core of the Nucleus Accumbens Mediates Cocaine-Induced Reinstatement of Drug-Seeking Behavior

The Journal of neuroscience, 2003-04, Vol.23 (8), p.3531-3537

2003

Volltextzugriff (PDF)

Low Dose Bexarotene Treatment Rescues Dopamine Neurons and Restores Behavioral Function in Models of Parkinson’s Disease

ACS chemical neuroscience, 2013-11, Vol.4 (11), p.1430-1438

2013

Volltextzugriff (PDF)

Estrogen Receptor Beta Selective Agonists as Agents to Treat Chemotherapeutic-Induced Neuropathic Pain

ACS chemical neuroscience, 2016-09, Vol.7 (9), p.1180-1187

2016

Volltextzugriff (PDF)

Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease

Behavioural pharmacology, 2011-10, Vol.22 (7), p.681

2011

Volltextzugriff (PDF)

Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios

Behavioural pharmacology, 2013-10, Vol.24 (7), p.628-632

2013

Volltextzugriff (PDF)

Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum

The Journal of neuroscience, 2005-05, Vol.25 (18), p.4512-4520

2005

Volltextzugriff (PDF)

Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease

Behavioural pharmacology, 2012-08, Vol.23 (4), p.426-433

2012

Volltextzugriff (PDF)

Activator of G Protein Signaling 3: A Gatekeeper of Cocaine Sensitization and Drug Seeking

Neuron (Cambridge, Mass.), 2004-04, Vol.42 (2), p.269-281

2004

Volltextzugriff (PDF)

AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

Neuropharmacology, 2010-02, Vol.58 (2), p.365-373

2010

Volltextzugriff (PDF)

AC-260584, an orally bioavailable M 1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

Neuropharmacology, 2010-02, Vol.58 (2), p.365-373

2010

Volltextzugriff (PDF)

Development of Nurr1-RXR Heterodimer Biased Agonists for Parkinson's Disease (P02.077)

Neurology, 2013-02, Vol.80 (7_supplement)

2013

Volltextzugriff (PDF)

N-Acetyl Cysteine-Induced Blockade of Cocaine-Induced Reinstatement

Annals of the New York Academy of Sciences, 2003-11, Vol.1003 (1), p.349-351

2003

Volltextzugriff (PDF)

Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli

Psychopharmacologia, 1997-05, Vol.131 (1), p.86-92

1997

Volltextzugriff (PDF)

AC-186, a Selective Nonsteroidal Estrogen Receptor β Agonist, Shows Gender Specific Neuroprotection in a Parkinson’s Disease Rat Model

ACS chemical neuroscience, 2013-09, Vol.4 (9), p.1249-1255

2013

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(52)
Dissertationen
(1)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(30)
Animals
(26)
Neurosciences
(24)
Male
(23)
Rats
(23)
Neurosciences & Neurology
(22)
Rats, Sprague-Dawley
(21)
Pharmacology & Pharmacy
(19)
Humans
(11)
Cocaine
(9)
Biological And Medical Sciences
(8)
Conditioning, Operant - Drug Effects
(8)
Reinforcement
(8)
Self Administration
(8)
Cocaine - Administration & Dosage
(7)
Disease Models, Animal
(7)
Dose-Response Relationship, Drug
(7)
Reinstatement
(7)
Behavior, Animal - Drug Effects
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis

The Circuitry Mediating Cocaine-Induced Reinstatement of Drug-Seeking Behavior

Brain circuitry and the reinstatement of cocaine-seeking behavior

Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking

Limbic and Motor Circuitry Underlying Footshock-Induced Reinstatement of Cocaine-Seeking Behavior

Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse

Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease

Adenosine A2a Blockade Prevents Synergy between μ-Opiate and Cannabinoid CB1 Receptors and Eliminates Heroin-Seeking Behavior in Addicted Rats

Safety and Tolerability of N-Acetylcysteine in Cocaine-Dependent Individuals

Activator of G Protein Signaling 3 Regulates Opiate Activation of Protein Kinase A Signaling and Relapse of Heroin-Seeking Behavior

Effects of haloperidol on cue-induced autonomic and behavioral indices of heroin reward and motivation

Prefrontal Glutamate Release into the Core of the Nucleus Accumbens Mediates Cocaine-Induced Reinstatement of Drug-Seeking Behavior

Low Dose Bexarotene Treatment Rescues Dopamine Neurons and Restores Behavioral Function in Models of Parkinson’s Disease

Estrogen Receptor Beta Selective Agonists as Agents to Treat Chemotherapeutic-Induced Neuropathic Pain

Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease

Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios

Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum

Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease

Activator of G Protein Signaling 3: A Gatekeeper of Cocaine Sensitization and Drug Seeking

AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

AC-260584, an orally bioavailable M 1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

Development of Nurr1-RXR Heterodimer Biased Agonists for Parkinson's Disease (P02.077)

N-Acetyl Cysteine-Induced Blockade of Cocaine-Induced Reinstatement

Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli

AC-186, a Selective Nonsteroidal Estrogen Receptor β Agonist, Shows Gender Specific Neuroprotection in a Parkinson’s Disease Rat Model

Suchergebnisse filtern